A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy - Top-Institutions - MDSpire

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy

  • By

  • Jan Kuska

  • Julia Kostyra

  • Lorraine Pinot

  • Evgeny Egorov

  • Nojan Jelveh

  • Lilian A. Martinez Carrera

  • Congcong Zhang

  • Svetlana Khorkova

  • Mario Assenmacher

  • Rimas Orentas

  • Sabine Mueller

  • José Villacorta Hidalgo

  • May 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Uniklinik Ulm
    Uniklinik Ulm

    Ulm, Germany

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy

  • by Jan Kuska, Julia Kostyra, Lorraine Pinot, Evgeny Egorov, Nojan Jelveh, Lilian A. Martinez Carrera, Congcong Zhang, Svetlana Khorkova, Mario Assenmacher, Rimas Orentas, Sabine Mueller, José Villacorta Hidalgo

  • May 22, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer